Lidský albumin
Economic Operator with Whom the Contract Has Been Concluded
| Show detail | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1438/2022-SML | 08. 09. 2022 | Takeda Pharmaceuticals Czech Republic s.r.o. | 4 752 000,00 | 4 320 000,00 | 4 752 000,00 | 4 320 000,00 | CZK |
Published Documents
| Show detail | |||||
|---|---|---|---|---|---|
| Písemná zpráva zadavatele_Lidský albumin-EP.pdf | Písemná zpráva zadavatele | 13. 09. 2022 06:36 | Dokument není zavirovaný |
Amendments to the Contract/Agreement
| 1 | 19. 07. 2023 | https://smlouvy.gov.cz/smlouva/25334171 | 1 425 600,00 | 1 296 000,00 |
List of Participants
| Show detail | ||||||
|---|---|---|---|---|---|---|
| Takeda Pharmaceuticals Czech Republic s.r.o. | Praha 2 | 4 752 000,00 | 4 320 000,00 | CZK |
Price Actually Paid in Each Year of Performance
| 1438/2022-SML | 2023 | 1 104 840,00 | 1 004 400,00 |
| 1438/2022-SML | 2022 | 158 400,00 | 144 000,00 |